Data compiled by Redley Lamar · ChainSifter Intelligence
9Suppliers
5Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Theriva Biologics, Inc. (TOVX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
26Total relationships
3Distinct source URLs
14High confidence
0.828Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from CADL graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from CADL graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from CADL g…
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
Reciprocal relationship from CGON graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from CGON graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from CGON g…
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
Reciprocal relationship from CLDWW graph: Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in…
Reciprocal relationship from GNLX graph: g process and had to demonstrate analytical comparability to the FDA in order to use Olvi-Vec manufactured by this process in our ongoing Phase 3 PRROC trial.…
Reciprocal relationship from MCRB graph: Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in …
prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Modifications or enhancem…
Theriva Biologics, Inc. Customers
Ticker
Name
Confidence
Evidence
RASAYANA
RASAYANA
92%
Under the terms of the Rasayana License Agreement, the Company received an upfront payment of Three Hundred Thousand Dollars ($ 300,000 ) from Rasayana on the effective date of the Rasayana License A…
RASAYANA-THERAPEUTICS-INC
RASAYANA-THERAPEUTICS-INC
92%
Under the terms of the Agreement, the Company received an upfront payment of Three Hundred Thousand Dollars ($300,000) from Rasayana on the Effective Date.
Reciprocal relationship from GNLX graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from GNLX graph: Reciprocal relationship from TOVX graph: Reciprocal relationship from GNLX g…
B-RILEY-SECURITIES-INC
B-RILEY-SECURITIES-INC
62%
exercise and other transactions described in the Inducement Agreement. Pursuant to the terms of an engagement letter, dated October 16, 2025 , by and between the Company and AGP, the Company agreed t…
NEW-TECHNOLOGIES-LIMITED
NEW-TECHNOLOGIES-LIMITED
62%
ion price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) a performance obligation is satisfied. 9 Table of Contents Theriv…
Theriva Biologics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
TOVX-DEBT-13069
Warrants outstanding: 13672173
90%
xbrl warrant detail from xbrl 2025-12-31.
TOVX-DEBT-13070
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-06-30.
TOVX-DEBT
Debt stack $1.7M
90%
Market cache reports total debt of $1.7M.
Theriva Biologics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Theriva Biologics, Inc..
Theriva Biologics, Inc. Ownership
Holder
Name
Confidence
Evidence
TOVX-OWNER-STONEX-GROUP-INC
Stonex Group Inc.
95%
13F/ownership overlay lists Stonex Group Inc.; shares held 37,217; ownership 0.08%; value $7,528; as of 2025-12-31.
TOVX-OWNER-VANGUARD-GROUP-INC
Vanguard Group Inc
95%
13F/ownership overlay lists Vanguard Group Inc; shares held 255,727; ownership 0.56%; value $51,733; as of 2025-12-31.
TOVX-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC
Geode Capital Management, LLC
95%
13F/ownership overlay lists Geode Capital Management, LLC; shares held 212,087; ownership 0.46%; value $42,905; as of 2025-12-31.
TOVX-OWNER-MORGAN-STANLEY
Morgan Stanley
95%
13F/ownership overlay lists Morgan Stanley; shares held 200,000; ownership 0.44%; value $40,459; as of 2025-12-31.
TOVX-OWNER-UBS-GROUP-AG
UBS Group AG
95%
13F/ownership overlay lists UBS Group AG; shares held 191,410; ownership 0.42%; value $38,722; as of 2025-12-31.
TOVX-OWNER-IKARIAN-CAPITAL-LLC
Ikarian Capital, LLC
95%
13F/ownership overlay lists Ikarian Capital, LLC; shares held 112,076; ownership 0.24%; value $22,672; as of 2025-12-31.
TOVX-OWNER-TWO-SIGMA-SECURITIES-LLC
Two Sigma Securities, LLC
95%
13F/ownership overlay lists Two Sigma Securities, LLC; shares held 42,893; ownership 0.09%; value $8,677; as of 2025-12-31.
TOVX-OWNER-DRW-SECURITIES-LLC
DRW Securities, LLC
95%
13F/ownership overlay lists DRW Securities, LLC; shares held 41,745; ownership 0.09%; value $8,445; as of 2025-12-31.
TOVX-OWNER-XTX-TOPCO-LTD
Xtx Topco Ltd
95%
13F/ownership overlay lists Xtx Topco Ltd; shares held 39,445; ownership 0.09%; value $7,979; as of 2025-12-31.
Theriva Biologics, Inc. Extended Supply Chain Network
